{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:32:12Z","timestamp":1788993132534,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.saa.2024.123986","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T17:35:03Z","timestamp":1707068103000},"page":"123986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["An eco-friendly one-pot spectrofluorimetric approach for the facile determination of overactive bladder drug, tolterodine: Application to dosage forms and biological fluids"],"prefix":"10.1016","volume":"311","author":[{"given":"Sayed M.","family":"Derayea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"Badr El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdelshakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Oraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2024.123986_b0005","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1517\/14656560903167965","article-title":"Tolterodine extended-release for overactive bladder","volume":"10","author":"Chung","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.saa.2024.123986_b0010","first-page":"337","article-title":"Pharmacologic management of overactive bladder","volume":"2","author":"Lam","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.saa.2024.123986_b0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0929-6646(10)60114-3","article-title":"Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms","volume":"109","author":"Ho","year":"2010","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.saa.2024.123986_b0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.microc.2012.06.010","article-title":"Electrically-enhanced microextraction combined with maltodextrin-modified capillary electrophoresis for quantification of tolterodine enantiomers in biological samples","volume":"106","author":"Fakhari","year":"2013","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2024.123986_b0025","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4314\/tjpr.v13i10.14","article-title":"Determination of tolterodine tartrate in bulk and formulation by extractive colorimetric method using Tropaeolin ooo-1","volume":"13","author":"Ganesh","year":"2014","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.saa.2024.123986_b0030","first-page":"2849","article-title":"Determination of tolterodine tartrate in pharmaceutical preparations using eosin, application to stability study","volume":"2","author":"Walash","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2024.123986_b0035","first-page":"1455","article-title":"New spectrophotometric method for estimation of tolterodine in bulk and pharmaceutical formulation","volume":"2","author":"Shetty","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2024.123986_b0040","first-page":"3845","article-title":"Spectrofluorimetric determination of tolterodine tartarate in pure form and pharmaceutical preparation","volume":"4","author":"Nassar","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2024.123986_b0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/bio.3475","article-title":"Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride","volume":"33","author":"El-Kimary","year":"2018","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.123986_b0050","first-page":"50","article-title":"Spectrofluorimetric method for the determination of tolterodine in human plasma and pharmaceutical preparations by derivatization with dansyl chloride, Bezmi\u00e2lem","volume":"5","author":"Tekkel\u0130","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.saa.2024.123986_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/00387010802428856","article-title":"Resonance Rayleigh Scattering Spectra of the Interaction Between Alizarin Green and Tolterodine Tartrate","volume":"42","author":"Qin","year":"2009","journal-title":"Spectrosc. Lett."},{"key":"10.1016\/j.saa.2024.123986_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/chromsci\/bmx081","article-title":"Novel validated HPTLC method for the analysis of two binary mixtures containing tamsulosin hydrochloride with antimuscarinic agents","volume":"56","author":"El-Kimary","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2024.123986_b0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00764-022-00198-w","article-title":"Simultaneous ultra-sensitive analysis of tamsulosin hydrochloride and tolterodine tartrate binary mixture in their dosage form via high-performance thin-layer chromatography with fluorimetric detection","volume":"35","author":"Rizk","year":"2022","journal-title":"JPC \u2013 Journal of Planar Chromatography \u2013 Modern TLC"},{"key":"10.1016\/j.saa.2024.123986_b0070","first-page":"81","article-title":"Simultaneous estimation of tolterodine tartrate and tamsulosin HCl by validated HPTLC assay method from combination capsule form","volume":"7","author":"Patel","year":"2015","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.saa.2024.123986_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1556\/AChrom.23.2011.1.9","article-title":"Development and validation of a simple, stability-indicating high-performance liquid chromatographic method for analysis of tolterodine tartrate in the bulk drug and in its tablet formulation","volume":"23","author":"Sinha","year":"2011","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.saa.2024.123986_b0080","first-page":"1549","article-title":"Stability Indicating RP-HPLC Method Development and Validation of Tolterodine Tartrate and its Degradant in its Capsule Dosage Form","volume":"9","author":"Urvi","year":"2017","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2024.123986_b0085","first-page":"89","article-title":"Development and validation of stability indicating assay method for estimation of Tamsulosin hydrochloride and Tolterodine tartrate in capsules","volume":"6","author":"Bhavsar","year":"2019","journal-title":"Int. J. Res. Anal. Rev"},{"key":"10.1016\/j.saa.2024.123986_b0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jpba.2004.03.026","article-title":"A validated chiral HPLC method for the enantiomeric separation of tolterodine tartarate","volume":"35","author":"Kumar","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.123986_b0095","first-page":"50","article-title":"Ultra sensitive UPLC method development and validation for the simultaneous estimation of tamsulosin hydrochloride and tolterodine tartrate in bulk and pharmaceutical dosage form, Academic","volume":"4","author":"Sebaiy","year":"2019","journal-title":"J. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.electacta.2019.02.086","article-title":"Detection of antimuscarinic agents tolterodine and fesoterodine and their metabolite 5-hydroxymethyl tolterodine by ion transfer voltammetry at a polarized room-temperature ionic liquid membrane","volume":"304","author":"Langmaier","year":"2019","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.saa.2024.123986_b0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1134\/S1061934814100049","article-title":"Sensitive and selective determination of tolterodine tartrate and its electrochemical investigation on solid carbon based electrodes","volume":"69","author":"Kul","year":"2014","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.arabjc.2016.07.015","article-title":"Validated electroanalytical determination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage forms and urine using modified carbon paste electrodes","volume":"11","author":"Attia","year":"2018","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.saa.2018.09.030","article-title":"Micelle and inclusion complex enhanced spectrofluorimetric methods for determination of Retigabine: Application in pharmaceutical and biological analysis","volume":"207","author":"Mostafa","year":"2019","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.123986_b0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/bio.3996","article-title":"Micelle-enhanced spectrofluorimetric determination of diphenhydramine: application to human plasma and its simultaneous determination with naproxen in pharmaceutical tablets","volume":"36","author":"Hammad","year":"2021","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.123986_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.104372","article-title":"Sensitive spectrofluorimetric assay based on micelle enhanced protocol for the determination of hepatitis C antiviral agent (simeprevir): Application to dosage form and human plasma","volume":"152","author":"Mohammed","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2024.123986_b0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molliq.2018.01.005","article-title":"Study of micelle and metal complexation-mediated fluorescence enhancements of raloxifene hydrochloride. Application to pharmaceutical analysis","volume":"252","author":"Ibrahim","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.saa.2024.123986_b0135","unstructured":"ICH Harmonised Tripartite Guideline, in: Validation of analytical procedures: text and methodology, 2005."},{"key":"10.1016\/j.saa.2024.123986_b0140","series-title":"Colorimetric and fluorimetric analysis of organic compounds and drugs","author":"Pesez","year":"1974"},{"key":"10.1016\/j.saa.2024.123986_b0145","first-page":"2287","article-title":"The United States Pharmacopoeia 30, the National Formulary 25 US Pharmacopeial Convention","author":"Rockville","year":"2007","journal-title":"Electronic Version"},{"key":"10.1016\/j.saa.2024.123986_b0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1478-4408.1999.tb00324.x","article-title":"The fluorescence of dihydroxyphenylalanine: the effects of protonation-deprotonation","volume":"115","author":"Smith","year":"1999","journal-title":"Color. Technol."},{"key":"10.1016\/j.saa.2024.123986_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00032716708051097","article-title":"Fluorescence Quantum Yields of Tryptophan and Tyrosine","volume":"1","author":"Chen","year":"1967","journal-title":"Anal. Lett."},{"key":"10.1016\/j.saa.2024.123986_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/137279","article-title":"Two validated spectrofluorometric methods for determination of gemifloxacin mesylate in tablets and human plasma","volume":"2013","author":"Atia","year":"2013","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0165","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/la060285e","article-title":"Effect of europium(III) chloride on the aggregation behavior of sodium dodecyl sulfate","volume":"22","author":"Valente","year":"2006","journal-title":"Langmuir: ACS Journal of Surfaces and Colloids"},{"key":"10.1016\/j.saa.2024.123986_b0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcis.2006.10.061","article-title":"Effect of terbium(III) chloride on the micellization properties of sodium decyl- and dodecyl-sulfate solutions","volume":"306","author":"Neves","year":"2007","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.saa.2024.123986_b0175","first-page":"135","article-title":"On-line micellar-enhanced spectrofluorimetric determination of rhodamine dye in cosmetics","volume":"75","author":"Wang","year":"2008","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2024.123986_b0180","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.saa.2015.08.040","article-title":"Micelle enhanced and native spectrofluorimetric methods for determination of sertindole using sodium dodecyl sulfate as sensitizing agent","volume":"153","author":"El-Kosasy","year":"2016","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.saa.2024.123986_b0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00604-005-0369-9","article-title":"Micelle-enhanced spectrofluorimetric method for the determination of antibacterial trovafloxacin in human urine and serum","volume":"150","author":"Vilchez","year":"2005","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.saa.2024.123986_b0190","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/bio.4257","article-title":"Micelle-enhanced spectrofluorimetric method for the rapid determination of bronchodilator terbutaline and its prodrug bambuterol: application for content uniformity test","volume":"37","author":"Nour-Eldeen","year":"2022","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.123986_b0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpba.2004.10.027","article-title":"Spectrofluorimetric and micelle-enhanced spectrofluorimetric determination of gatifloxacin in human urine and serum","volume":"37","author":"Ocana","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.123986_b0200","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1139\/v78-206","article-title":"Excited state acid\u2013base equilibrium of tyrosine","volume":"56","author":"Rayner","year":"1978","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0205","series-title":"Profiles of Drug Substances, Excipients and Related Methodology","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/bs.podrm.2017.02.007","article-title":"Chapter Seven - Tolterodine Tartrate","author":"Ananchenko","year":"2017"},{"key":"10.1016\/j.saa.2024.123986_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122948","article-title":"Augmentation of Brexpiprazole fluorescence through photoinduced electron transfer inhibition for the sensitive spectrofluorimetric assay of pharmaceutical dosage forms and spiked human plasm; Application to Content Uniformity Testing","volume":"301","author":"Derayea","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.123986_b0215","series-title":"Green analytical chemistry: theory and practice","author":"De La Guardia","year":"2010"},{"key":"10.1016\/j.saa.2024.123986_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.saa.2024.123986_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122265","article-title":"Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma","volume":"290","author":"Batubara","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.123986_b0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13065-023-00967-6","article-title":"Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation","volume":"17","author":"Batubara","year":"2023","journal-title":"BMC Chemistry"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524001525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524001525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:42:20Z","timestamp":1761360140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142524001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S1386142524001525"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2024.123986","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An eco-friendly one-pot spectrofluorimetric approach for the facile determination of overactive bladder drug, tolterodine: Application to dosage forms and biological fluids","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2024.123986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123986"}}